Ogeta says Raila hospital-gown video was filmed in Dubai after 2020 surgery

Maurice Ogeta, the longtime aide to former Kenyan Prime Minister Raila Odinga, said a viral video showing Odinga in a hospital gown was filmed in Dubai after an earlier surgery, correcting claims that it showed his final days in India.

The clarification matters for UAE healthcare operators because Dubai remains a treatment destination for foreign political figures, high-net-worth patients and diaspora families. For clinics and hospitals, the highest-risk readers are COOs, CMOs and medical directors. The issue is practical: patient images can move faster than consent files, especially when a known person is treated in a UAE facility.

What Ogeta said

Ogeta made the clarification during Kenyan television interviews aired on 11 October 2026 and reported by Kenyan outlets on 12 October 2026. People Daily reported that Ogeta said the footage was recorded during Odinga's first surgery in Dubai. Y News reported that the clip related to Odinga's 2020 treatment in Dubai.

"That was the previous clip when we were in Dubai when he did his first surgery," Ogeta said, according to Y News.

The video showed Odinga walking in a hospital setting with Ogeta behind him. It resurfaced after Odinga's death and was widely interpreted online as footage from India. Kenyan reports said Odinga died on 15 October 2025 after collapsing during a morning walk in Kerala and being taken to Devamatha Hospital in Koothattukulam.

For Dubai providers, the story is less about one patient and more about media control around international care. If a patient is a public figure, a 20-second corridor clip can become a cross-border reputational event years after discharge.

What Dubai providers should check

The relevant regulator in Dubai is the Dubai Health Authority (DHA). DHA's Sheryan system licenses healthcare facilities and professionals, and the Dubai Medical Registry is the public route for checking licensed facilities and professionals.

DHA has already addressed social-media risk. Its 2022 standards for medical advertisement content on social media apply to DHA-licensed facilities and healthcare professionals. The standards require social-media healthcare content to comply with UAE federal and local law, and require official facility accounts to state the relevant medical advertisement licence number issued by the Ministry of Health and Prevention (MOHAP).

A separate DHA circular dated 7 May 2018 reminded private-sector health facilities and professionals that video filming, recording and live broadcasting in operating rooms should be prevented. The circular named patient rights and privacy as a concern even where a patient has consented.

• COOs should confirm who may film inside wards, corridors and recovery areas, and where written consent is stored.
• CMOs should verify that every health-related social post has the required advertising approval before publication.
• Medical directors should confirm that doctors, nurses, aides and visiting companions understand the facility's phone-use rules.
• CFOs should ask insurers whether a VIP or overseas-patient package changes pre-authorisation, billing or discharge documentation.

Dubai's Executive Council Resolution No. 49 of 2024 also lists compliance failures relevant to this case. The schedule includes publishing a health promotion without DHA authorisation and posting content, images or advertisements in a facility or on social media in a manner that conflicts with professional ethics.

Insurers and patients have their own exposure

Insurers should treat viral clinical footage as a claims-administration risk. A foreign patient may be self-pay, insured under an international plan, or covered through a UAE network policy. The applicable payer could vary by emirate, employer, residency status and policy wording. Providers should verify coverage directly through the payer portal or written pre-authorisation rather than relying on a patient's social status or nationality.

For Abu Dhabi, the relevant regulator is the Department of Health Abu Dhabi (DOH). DOH's public tools include facility, professional and insurance-product search tools. For Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, the relevant regulator is MOHAP, which maintains a medical facilities directory.

Patients and families should ask three questions before treatment in Dubai or elsewhere in the UAE: which regulator licenses the facility, which insurer or self-pay package covers the episode, and who may record or share images inside the facility. If the provider cannot answer those questions in writing, the patient has a governance problem before treatment starts.

Operators can use the UAE Open Healthcare Directory to check licensed hospitals and providers across all seven emirates before making referral, network or patient-navigation decisions.